Leading international clinicians, all experts in their field, will be onsite in Madrid to share their experiences with the new solutions. They will also demonstrate how these can help clinicians to further shorten time-to-teeth and to improve long-term clinical results. Participants will be able to further explore the innovations and more through a number of dedicated hands-on sessions and product demonstrations.
Held at the Marriott Auditorium Hotel & Conference Center from 27-29 June, the Nobel Biocare Global Symposium in Madrid is kicking off the new global event series which was announced last year to extend the originally planned Nobel Biocare Global Symposium 2019 in Las Vegas. Following the meeting in the Spanish capital are two additional Global Symposia in Las Vegas in 2020 as well as in Tokyo in 2021. Through this unique event concept, more dental professionals than ever will be able to experience this new wave of innovations by Nobel Biocare first hand.
Commenting on the upcoming events and launches, Hans Geiselhöringer, President of Nobel Biocare said: “We are excited to welcome dental professionals from all over the world to Madrid in June where we will present the next revolutionary steps in dental implant care with a host of new and forward-thinking innovations. With two more events to come, it will be a once-in-a-generation opportunity to experience true game changers in implant dentistry.”
More information about the Nobel Biocare Global Symposium events series as well as how to register for the kick-off meeting in Madrid can be found online at www.nobelbiocare.com/global-symposia. Dental professionals who already registered for the original Nobel Biocare Global Symposium in Las Vegas will be given the opportunity to transfer their registration to any of the three upcoming events.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.